Locations:
Search IconSearch
January 28, 2020/Cancer

Breaking Ground: Cleveland Clinic Abu Dhabi’s New Approach to Fighting Cancer

A central hub for patient care and research expands Cleveland Clinic's world-class care around the globe

Cleveland Clinic Abu Dhabi Cancer Center

As the third leading cause of death in Abu Dhabi, cancer affects millions of patients and families across the region. Cleveland Clinic Abu Dhabi has broken ground on a state-of-the-art oncology center, a significant step in the UAE’s fight against the disease. The center is designed to meet the specific needs of cancer patients and their treatments and will bring an integrated and transformative approach to diagnosing and treating cancer to the UAE.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“One of the main reasons patients travel abroad is to seek cancer treatment,” says Stephen Grobmyer, MD, Chair of Cleveland Clinic Abu Dhabi’s Oncology Institute. “Patients who come to us will now have access to comprehensive, personalized care at a single location, as well as an expanded range of treatments available.”

Dr. Grobmyer will lead the new 18,767 square meter purpose-built center modelled on Cleveland Clinic’s Taussig Cancer Center, which is ranked in the top 10 hospitals for cancer care nationally by U.S. News & World Report. He is an expert in the management of breast cancer and led the Cleveland Clinic Comprehensive Breast Cancer Program before coming to Cleveland Clinic Abu Dhabi.

“In the U.S., I saw how a change to centralized services positively impacted patients and their families, and we are thrilled to bring this model of care to the people of the UAE,” says Dr. Grobmyer.

A central hub for patient care and research

Designed with patients in mind, the nine-story facility will have dedicated clinical practice areas for advanced imaging, infusion, radiation and chemotherapy, as well as a connection to the main hospital’s surgical areas. The practice areas will have space for subspecialized nurses, social workers and patient support services.

The layout of each floor unites a range of complementary specialties, enhancing collaboration and enabling patients to receive most of their treatment in one area — a unique approach for patient care in the region. The center will have 24 exam rooms, 24 infusion rooms, two procedure rooms and an area devoted to specialty women’s services.

The building is designed to ensure the most comfortable flow for patients, provide an abundance of natural light and offer the optimal combination of clinical care with oncology patient support services and prayer rooms for patients.

In the future, it will also be a home for cancer research in the region, with a centralized hub for existing high-level treatment technology. “Our priority will be to answer cancer research questions that are specifically relevant to the people of the UAE and the regions that we serve. Areas of focus will be cancer screening and prevention, and investigating new technologies for cancer treatment.”

Expanding world-class care across the world

Cleveland Clinic Abu Dhabi’s current cancer services include positron emission tomography and computed tomography (PET-CT) for cancer diagnoses as well as advanced magnetic resonance imaging (MRI). Presently, advanced surgical procedures including robotics are performed for cancer patients with excellent results. Chemotherapy and other infusion treatments for cancer are also provided and supported by disease-specific tumor boards. When the center opens in 2022, services will expand to include radiation oncology, and disease-specific multidisciplinary teams will be fully enabled in the new oncology building to offer patients timely, state-of-the-art care in a supportive environment.

Advertisement

The new oncology center expands Cleveland Clinic’s efforts to bring world-class care to patients around the globe. “This really is a groundbreaking approach to cancer care that will not only serve the patients of the nation, but of the region and globe as well,” says Dr. Grobmyer. “This center will be the premier destination for cancer care in the Gulf region.”

Advertisement

Related Articles

Dr. Holly Pederson
July 25, 2024/Cancer/Research
Evaluating Risk Scores for Triple-Negative Breast Cancer in Black Women (Podcast)

Polygenic risk score could help predict who will develop this aggressive breast cancer

Reviewing dental scans
July 8, 2024/Cancer
A Call for More Interdisciplinary and Preventive Care in New Osteoradionecrosis Guidelines

New guidelines offer insight into emerging therapies, dental issues and more

Dr. AlHilli
July 3, 2024/Cancer/Patient Support
Prehabilitation Program Aims to Improve Outcomes for Older Patients with Ovarian or Pancreatic Cancer

Clinical trial to assess the value of nutritional, physical therapy and social supports prior to preoperative chemotherapy

Dr. Nahleh
June 26, 2024/Cancer/Patient Support
Systemic Treatment a Major Factor Impacting Survival of Patients with Breast Cancer with Brain Metastasis

Research demonstrates improved overall survival for patients receiving comprehensive treatment for breast cancer in addition to radiation or surgical intervention for brain cancer

Image showing Dr. Gupta
June 20, 2024/Cancer/Research
Trailblazing Urothelial Cancer Treatments (Podcast)

Platinum-eligible phase 3 trial of enfortumab vedotin and pembrolizumab yields ‘unprecedented data’

Dr. Grobmyer and team
June 14, 2024/Cancer/Innovations
Fatima bint Mubarak Center Addresses Inequities in Cancer Care

Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates

Lung cancer cells
June 5, 2024/Cancer/Research
Impact of Tumor Burden on Survival for Patients with EGFR-Mutant NSCLC Treated with Osimertinib

Extent of baseline burden impacts progression-free and overall survival

cancer cells
June 4, 2024/Cancer/Research
Researchers Identify Tumor Microbiome Differences in Early- vs. Average-Onset Pancreatic Adenocarcinoma

Further study warranted to better understand the clinical implications of these findings

Ad